scispace - formally typeset
A

Ana Rey-Rico

Researcher at Saarland University

Publications -  76
Citations -  2004

Ana Rey-Rico is an academic researcher from Saarland University. The author has contributed to research in topics: Chondrogenesis & Cartilage. The author has an hindex of 25, co-authored 73 publications receiving 1639 citations. Previous affiliations of Ana Rey-Rico include Sorbonne & University of Santiago de Compostela.

Papers
More filters
Journal ArticleDOI

Supramolecular Cyclodextrin-Based Drug Nanocarriers

TL;DR: In this paper, a review of CD-based supramolecular nanosystems with a special focus on the advances materialized in the last five years, including clinical trials is presented.
Journal ArticleDOI

TGF-β gene transfer and overexpression via rAAV vectors stimulates chondrogenic events in human bone marrow aspirates

TL;DR: Applying the candidate TGF‐β vector to human bone marrow aspirates was capable of reducing the hypertrophic and osteogenic differentiation processes in the aspirates, showing the potential benefits of using this particular vector to directly modify marrow concentrates to generate single‐step, effective approaches that aim at improving articular cartilage repair in vivo.
Journal ArticleDOI

Enhanced Chondrogenic Differentiation Activities in Human Bone Marrow Aspirates via sox9 Overexpression Mediated by pNaSS-Grafted PCL Film-Guided rAAV Gene Transfer

TL;DR: The findings show the benefits of targeting patients’ bone marrow via PCL film-guided therapeutic rAAV (sox9) delivery as an off-the-shelf system for future strategies to enhance cartilage repair in translational applications.
Journal ArticleDOI

Controlled Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy

TL;DR: The aim of this work was to design for the first time hydrogel contact lenses that can act as platforms for the controlled delivery of viral vectors to the eye in an effective way with improved patient compliance.
Journal ArticleDOI

Scaffold-Mediated Gene Delivery for Osteochondral Repair.

TL;DR: An overview of the variety of biomaterials employed as nonviral or viral gene carriers for osteochondral repair approaches both in vitro and in vivo, including hydrogels, solid scaffolds, and hybrid materials shows that a site-specific delivery of therapeutic gene vectors in the context of acellular or cellular strategies allows for a spatial and temporal control of osteochondrals neotissue composition in vitro.